114 related articles for article (PubMed ID: 29069806)
1. Modulating BAP1 expression affects ROS homeostasis, cell motility and mitochondrial function.
Hebert L; Bellanger D; Guillas C; Campagne A; Dingli F; Loew D; Fievet A; Jacquemin V; Popova T; Jean D; Mechta-Grigoriou F; Margueron R; Stern MH
Oncotarget; 2017 Sep; 8(42):72513-72527. PubMed ID: 29069806
[TBL] [Abstract][Full Text] [Related]
2. The BAP1/ASXL2 Histone H2A Deubiquitinase Complex Regulates Cell Proliferation and Is Disrupted in Cancer.
Daou S; Hammond-Martel I; Mashtalir N; Barbour H; Gagnon J; Iannantuono NV; Nkwe NS; Motorina A; Pak H; Yu H; Wurtele H; Milot E; Mallette FA; Carbone M; Affar el B
J Biol Chem; 2015 Nov; 290(48):28643-63. PubMed ID: 26416890
[TBL] [Abstract][Full Text] [Related]
3. Structural basis of histone H2A lysine 119 deubiquitination by Polycomb Repressive Deubiquitinase BAP1/ASXL1.
Thomas JF; Valencia-Sánchez MI; Tamburri S; Gloor SL; Rustichelli S; Godínez-López V; De Ioannes P; Lee R; Abini-Agbomson S; Gretarsson K; Burg JM; Hickman AR; Sun L; Gopinath S; Taylor H; Meiners MJ; Cheek MA; Rice W; Nudler E; Lu C; Keogh MC; Pasini D; Armache KJ
bioRxiv; 2023 Feb; ():. PubMed ID: 36865140
[TBL] [Abstract][Full Text] [Related]
4. Structural basis of histone H2A lysine 119 deubiquitination by Polycomb repressive deubiquitinase BAP1/ASXL1.
Thomas JF; Valencia-Sánchez MI; Tamburri S; Gloor SL; Rustichelli S; Godínez-López V; De Ioannes P; Lee R; Abini-Agbomson S; Gretarsson K; Burg JM; Hickman AR; Sun L; Gopinath S; Taylor HF; Sun ZW; Ezell RJ; Vaidya A; Meiners MJ; Cheek MA; Rice WJ; Svetlov V; Nudler E; Lu C; Keogh MC; Pasini D; Armache KJ
Sci Adv; 2023 Aug; 9(32):eadg9832. PubMed ID: 37556531
[TBL] [Abstract][Full Text] [Related]
5. PR-DUB maintains the expression of critical genes through FOXK1/2- and ASXL1/2/3-dependent recruitment to chromatin and H2AK119ub1 deubiquitination.
Kolovos P; Nishimura K; Sankar A; Sidoli S; Cloos PA; Helin K; Christensen J
Genome Res; 2020 Aug; 30(8):1119-1130. PubMed ID: 32747411
[TBL] [Abstract][Full Text] [Related]
6. BAP1/ASXL1 recruitment and activation for H2A deubiquitination.
Sahtoe DD; van Dijk WJ; Ekkebus R; Ovaa H; Sixma TK
Nat Commun; 2016 Jan; 7():10292. PubMed ID: 26739236
[TBL] [Abstract][Full Text] [Related]
7. BAP1 complex promotes transcription by opposing PRC1-mediated H2A ubiquitylation.
Campagne A; Lee MK; Zielinski D; Michaud A; Le Corre S; Dingli F; Chen H; Shahidian LZ; Vassilev I; Servant N; Loew D; Pasmant E; Postel-Vinay S; Wassef M; Margueron R
Nat Commun; 2019 Jan; 10(1):348. PubMed ID: 30664650
[TBL] [Abstract][Full Text] [Related]
8. Reducing hyperactivated BAP1 attenuates mutant ASXL1-driven myeloid malignancies in human haematopoietic cells.
Bai J; Chen Z; Chen C; Zhang M; Zhang Y; Song J; Yuan J; Jiang X; Xing W; Yang J; Bai J; Zhou Y
Cancer Lett; 2021 Oct; 519():78-90. PubMed ID: 34186160
[TBL] [Abstract][Full Text] [Related]
9. BAP1/ASXL complex modulation regulates epithelial-mesenchymal transition during trophoblast differentiation and invasion.
Perez-Garcia V; Lea G; Lopez-Jimenez P; Okkenhaug H; Burton GJ; Moffett A; Turco MY; Hemberger M
Elife; 2021 Jun; 10():. PubMed ID: 34170818
[TBL] [Abstract][Full Text] [Related]
10. Monoubiquitination of ASXLs controls the deubiquitinase activity of the tumor suppressor BAP1.
Daou S; Barbour H; Ahmed O; Masclef L; Baril C; Sen Nkwe N; Tchelougou D; Uriarte M; Bonneil E; Ceccarelli D; Mashtalir N; Tanji M; Masson JY; Thibault P; Sicheri F; Yang H; Carbone M; Therrien M; Affar EB
Nat Commun; 2018 Oct; 9(1):4385. PubMed ID: 30349006
[TBL] [Abstract][Full Text] [Related]
11. [Molecular mechanisms by which the mutant ASXL1/BAP1 complex aggravates myeloid leukemia].
Asada S
Rinsho Ketsueki; 2020; 61(4):392-405. PubMed ID: 32378586
[TBL] [Abstract][Full Text] [Related]
12. Structural Basis for the Activation of the Deubiquitinase Calypso by the Polycomb Protein ASX.
De I; Chittock EC; Grötsch H; Miller TCR; McCarthy AA; Müller CW
Structure; 2019 Mar; 27(3):528-536.e4. PubMed ID: 30639226
[TBL] [Abstract][Full Text] [Related]
13. The ASXL-BAP1 axis: new factors in myelopoiesis, cancer and epigenetics.
Abdel-Wahab O; Dey A
Leukemia; 2013 Jan; 27(1):10-5. PubMed ID: 23147254
[TBL] [Abstract][Full Text] [Related]
14. BAP1 maintains chromosome stability by stabilizing DIDO1 in renal cell carcinoma.
Xiao J; Zhang R; Peng J; Yang Z
Am J Cancer Res; 2020; 10(5):1455-1466. PubMed ID: 32509391
[TBL] [Abstract][Full Text] [Related]
15. NeuCode Proteomics Reveals Bap1 Regulation of Metabolism.
Baughman JM; Rose CM; Kolumam G; Webster JD; Wilkerson EM; Merrill AE; Rhoads TW; Noubade R; Katavolos P; Lesch J; Stapleton DS; Rabaglia ME; Schueler KL; Asuncion R; Domeyer M; Zavala-Solorio J; Reich M; DeVoss J; Keller MP; Attie AD; Hebert AS; Westphall MS; Coon JJ; Kirkpatrick DS; Dey A
Cell Rep; 2016 Jul; 16(2):583-595. PubMed ID: 27373151
[TBL] [Abstract][Full Text] [Related]
16. The Functions and Mechanisms of PR-DUB in Malignancy.
Cao L; Li R; Wu X
Front Mol Biosci; 2021; 8():657150. PubMed ID: 33796551
[TBL] [Abstract][Full Text] [Related]
17. BAP1 suppresses tumor development by inducing ferroptosis upon SLC7A11 repression.
Zhang Y; Zhuang L; Gan B
Mol Cell Oncol; 2019; 6(1):1536845. PubMed ID: 30788415
[TBL] [Abstract][Full Text] [Related]
18. Histone H2A monoubiquitination and Polycomb repression: the missing pieces of the puzzle.
Scheuermann JC; Gutiérrez L; Müller J
Fly (Austin); 2012; 6(3):162-8. PubMed ID: 22836728
[TBL] [Abstract][Full Text] [Related]
19. BAP1 in cancer: epigenetic stability and genome integrity.
Caporali S; Butera A; Amelio I
Discov Oncol; 2022 Nov; 13(1):117. PubMed ID: 36318367
[TBL] [Abstract][Full Text] [Related]
20. Emerging multifaceted roles of BAP1 complexes in biological processes.
Szczepanski AP; Wang L
Cell Death Discov; 2021 Jan; 7(1):20. PubMed ID: 33483476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
